Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry, & Status of FDA Orange Book Exclusivities covering Aluminum Salt Ibuprofen

Client Email

Product

Aluminum Salt Ibuprofen
U.S. EXCLUSIVITIES

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Aluminum Salt Ibuprofen

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

94 API Suppliers, 60 USDMF, 13 CEP/COS, 4 JDMF, 6 EU WC, 91 KDMF, 37 NDC API, 36 Listed Suppliers, $ API Reference Price

94 API Suppliers
60 USDMF
13 CEP/COS
4 JDMF
6 EU WC
91 KDMF
37 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

28 Drugs in Development

28 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

1112 FDF Dossiers, 318 FDA Orange Book, 332 Europe, 82 Canada, 15 Australia, 116 South Africa, 249 Listed Dossiers

1112 FDF Dossiers
318 FDA Orange Book
332 Europe
82 Canada
15 Australia
116 South Africa
249 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 200MG, TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT, SUSPENSION;ORAL - 100MG/5ML, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, TABLET;ORAL - 38MG;200MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, TABLET;ORAL - 200MG;10MG

TABLET;ORAL - 200MG
TABLET;ORAL - 200MG
TABLET;ORAL - 200MG;30MG
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT
SUSPENSION;ORAL - 100MG/5ML
CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG
CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
TABLET;ORAL - 38MG;200MG
TABLET;ORAL - 2MG;200MG;30MG
TABLET;ORAL - 4MG;200MG;10MG
TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 19 DKSH, 2 Jai Radhe Sales, 3 Pharm-RX Chemical, 12 Boai NKY Pharmaceuticals Ltd, 16 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

130 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 58 Direct Compression, 50 Thickeners and Stabilizers, 44 Disintegrants & Superdisintegrants, 43 Solubilizers, 38 Controlled & Modified Release, 35 Parenteral, 35 Granulation, 34 Topical, 34 Film Formers & Plasticizers, 33 Taste Masking, 31 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 22 Co-Processed Excipients, 20 Emulsifying Agents, 13 API Stability Enhancers, 12 Rheology Modifiers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

130 Fillers, Diluents & Binders
63 Coating Systems & Additives
58 Direct Compression
50 Thickeners and Stabilizers
44 Disintegrants & Superdisintegrants
43 Solubilizers
38 Controlled & Modified Release
35 Parenteral
35 Granulation
34 Topical
34 Film Formers & Plasticizers
33 Taste Masking
31 Lubricants & Glidants
22 Chewable & Orodispersible Aids
22 Co-Processed Excipients
20 Emulsifying Agents
13 API Stability Enhancers
12 Rheology Modifiers
9 Empty Capsules
8 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

7 DATA COMPILATION #PharmaFlow, 171 NEWS #PharmaBuzz

7 DATA COMPILATION #PharmaFlow
171 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 262 Finished Drug Prices

2 US Medicaid Prescriptions
262 Finished Drug Prices

MARKET PLACE

86 APIs, 38 FDF Dossiers

86 APIs
38 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 8 US Exclusivities, 4 Health Canada Patents

26 US Patents
8 US Exclusivities
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 27 Others

4 EDQM
2 USP
27 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

2 BioAnalytical Methods
1 Analytical Methods

$ API Ref.Price (USD/KG) : 12 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

8 All

01 1AFT PHARMS LTD

02 6CUMBERLAND PHARMS

03 1GLENMARK PHARMS LTD

filter Product Reset all filters

8 All

01 2ACETAMINOPHEN; IBUPROFEN

02 6IBUPROFEN

filter Exclusivity Expiration Date Reset all filters

8 All

01 12024-11-03

02 32024-11-19

03 12026-03-01

04 32026-05-11

filter Exclusivity Code Reset all filters

8 All

01 3M-128

02 1NP

03 3NPP

04 1PC

US Patents
US Exclusivities
Health Canada Patents

Product Main Page

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

2

Exclusivity Details

01

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

1

Exclusivity Details

02

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

1

Exclusivity Details

03

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

GLENMARK PHARMS LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

PC

Exclusivity Expiration Date

2024-11-03

Application Number

218311

Product Number

1

Exclusivity Details

04

GLENMARK PHARMS LTD

ACETAMINOPHEN; IBUPROFEN

AAPS 2024

Not Confirmed

GLENMARK PHARMS LTD

India

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : PC

Exclusivity Expiration Date : 2024-11-03

Application Number : 218311

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

AFT PHARMS LTD

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

ACETAMINOPHEN; IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NP

Exclusivity Expiration Date

2026-03-01

Application Number

209471

Product Number

1

Exclusivity Details

05

AFT PHARMS LTD

ACETAMINOPHEN; IBUPROFEN

AAPS 2024

Not Confirmed

AFT PHARMS LTD

New Zealand

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

ACETAMINOPHEN; IBUPROFEN

Exclusivity Code : NP

Exclusivity Expiration Date : 2026-03-01

Application Number : 209471

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

3

Exclusivity Details

06

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

M-128

Exclusivity Expiration Date

2024-11-19

Application Number

22348

Product Number

3

Exclusivity Details

07

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : M-128

Exclusivity Expiration Date : 2024-11-19

Application Number : 22348

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

CUMBERLAND PHARMS

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

IBUPROFEN

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

NPP

Exclusivity Expiration Date

2026-05-11

Application Number

22348

Product Number

2

Exclusivity Details

08

CUMBERLAND PHARMS

AAPS 2024

Not Confirmed

CUMBERLAND PHARMS

U.S.A

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-05-11

Application Number : 22348

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?